SRPT vs MSFT: Which Stock is Better?

Side-by-side comparison of Sarepta Therapeutics Inc and Microsoft Corporation in 2026

Comparison Updated:

SRPT

Sarepta Therapeutics Inc

$20.76

MSFT

Microsoft Corporation

$510.89

Key Metrics Comparison

MetricSRPTMSFTWinner
Market Cap$2.34B$3.71TMSFT
P/E Ratio8.4033.89SRPT
EPS (TTM)$2.47$14.08MSFT
Revenue Growth53.0%18.4%SRPT
Gross Margin0.0%67.9%MSFT

Analyze SRPT

Full quant analysis

Analyze MSFT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is SRPT or MSFT a better investment?

Comparing SRPT and MSFT: Sarepta Therapeutics Inc has a market cap of $2.34B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between SRPT and MSFT?

SRPT (Sarepta Therapeutics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: SRPT or MSFT?

Based on P/E ratios, SRPT trades at a lower multiple (8.4x vs 33.9x).

Which is growing faster: SRPT or MSFT?

SRPT has higher revenue growth at 53.0% vs 18.4% for MSFT.

Which company is more profitable: SRPT or MSFT?

Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for SRPT.

Which is the larger company: SRPT or MSFT?

Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $2.34B for SRPT.

Should I buy SRPT or MSFT in 2026?

Both SRPT and MSFT have investment merit. SRPT trades at $20.76 while MSFT trades at $510.89. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between SRPT and MSFT stock?

Key differences: Market Cap ($2.34B vs $3.71T), P/E Ratio (8.4x vs 33.9x), Revenue Growth (53.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).

Should I buy SRPT or MSFT in 2026?

The choice between SRPT and MSFT depends on your investment goals. SRPT shows higher revenue growth (53.0%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.

What is the market cap comparison between SRPT and MSFT?

SRPT (Sarepta Therapeutics Inc) has a market cap of $2.34B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.

Popular Stock Comparisons